Observe Medical ASA announced the appointment of Carsten Trygve Bøgh as Chief Technology Officer (CTO), effective 2 October 2022. Mr. Bøgh has a long-standing medtech career, having led several innovative product launches, delivered impactful results, and reached value-inflection milestones for companies. Mr. Bøgh brings more than 25 years of strategic leadership experience in medtech.

He joins Observe Medical from Fresenius Medical Care Global research and development in Germany, the world's leading provider of products and services for individuals with renal diseases, where he held the role of Senior Vice President, Global Product Development. Under his leadership, three new innovative dialysis Therapy Systems were launched in APAC/China, EMEA and the US, and a new and innovative Dialyzer for improved performance and biocompatibility. Mr. Bøgh also introduced the first App-based Nurse and Caretaker Cloud-based IT platform, which increased efficiency and lowered clinic costs.

Previously, he served as the Senior Vice President, Global Portfolio Management at Fresenius Medical Care. Before joining Fresenius, he held senior management positions at Oticon A/S, an innovative hearing aid manufacturer based in Denmark. Mr. Bøgh holds an Engineering Technology Manager (ETM) degree from Copenhagen University College and an Ms.Sc.EE, Medical Ultrasound from the Technical University of Denmark.